Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis-Reference-Cited by-同舟云学术

Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis

Published:2014-01-24 Issue:11 Volume:49 Page:1076-1089
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol.

Author:

Mazurek Henryk¹,Chiron Raphaël²,Kucerova Tereza³,Geidel Christian⁴,Bolbas Katalin⁵,Chuchalin Alexander⁶,Blanco-Aparicio Marina⁷,Santoro Debora⁸,Varoli Guido⁸,Zibellini Marco⁸,Cicirello Helen G.⁹,Antipkin Yuriy G.¹⁰

Affiliation:

1. Instytut Gruźlicy i Chorób Pluc; Oddzial Terenowy im. Jana i Ireny Rudników w Rabce-Zdrój; Klinika Pneumonologii i Mukowiscydozy; Rabka-Zdrój Poland

2. Hôpital Arnaud de Villeneuve; Centre des Maladies Respiratoires; Montpellier France

3. Centrum Pro Cystickou Fibrosu; Pediatricka Klinika; Fakultní nemocnice v Motole; Praha Czech Republic

4. Justus-Liebig Universität Gießen; Pädiatrische Pneumologie und Allergologie; Mukovizidose-Zentrum; Zentrum für Kinderheilkunde und Jugendmedizin; Gießen Germany

5. Kaposi Mór Oktatókórház; Gyermekpulmonológiai Részleg; Mosdós Hungary

6. Federal State Institution-Scientific Research Pulmonology Institute under the Roszdrav Laboratory of Cystic Fibrosis; Moscow Russia

7. Complejo Hospitalario Universitario La Coruña; Servicio de Neumologia; A Coruña Spain

8. Corporate Clinical Development; Chiesi Farmaceutici, S.p.A.; Parma Italy

9. Chiesi Pharmaceuticals, Inc.; Rockville Maryland

10. Institute of Pediatrics; Obstetrics and Gynecology; Department of Respiratory Diseases and Ecological Problems of Children's Health; Kyiv Ukraine

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference36 articles.

1. Management of pulmonary disease in patients with cystic fibrosis;Ramsey;N Engl J Med,1996

2. Pathophysiology and management of pulmonary infections in cystic fibrosis;Gibson;Am J Respir Crti Care Med,2003

3. Cystic fibrosis pulmonary guidelines; chronic medications for maintenance of lung health;Flume;Am J Respir Crit Care Med,2007

4. Prediction of mortality in patients with cystic fibrosis;Kerem;N Engl J Med,1992

5. Cystic Fibrosis Foundation

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis;Cochrane Database of Systematic Reviews;2022-11-14

2. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis;Cochrane Database of Systematic Reviews;2022-08-01

3. Inhaled Medicines: Past, Present, and Future;Pharmacological Reviews;2022-01

4. Pulmonary biofilm-based chronic infections and inhaled treatment strategies;International Journal of Pharmaceutics;2021-07

5. Cough as an adverse effect on inhalation pharmaceutical products;British Journal of Pharmacology;2020-08-07